Market Overview:
The global diabetic lancets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetes and its complications, and technological advancements in lancing devices. Based on type, the global diabetic lancets market can be segmented into reusable lancets and disposable lancets. The disposable lancet segment is expected to grow at a higher CAGR than the reusable lancet segment during the forecast period from 2018 to 2030. This growth can be attributed to factors such as ease of use and disposal, lower cost, and increasing preference for disposables over reusables among patients owing to hygiene concerns. Based on application, the global diabetic lancets market can be divided into hospital settings, clinic settings, and other settings (home care/self-care). The hospital setting segment is expected to account for a larger share of the global diabetic lancets market than other segments during the forecast period from 2018to 2030 due high incidence rate of diabetes in hospitals across regions worldwide coupled with growing demand for advanced diagnostic procedures such as point-of-care testing (POCT) in these settings.
Product Definition:
A diabetic lancet is a small, sharp needle used to prick the skin to obtain a blood sample. Lancets are often used by people with diabetes to test their blood sugar levels.
Reusable Lancets:
Reusable lancets are used for drawing blood from patients and are one of the most important devices in blood glucose monitoring. The device consists of a needle that is retractable and can be reused after proper sterilization. Reusable lancets reduce the risk of infections as compared to disposable ones, which is one of the major factors contributing to its growth factor in the market for diabetic lancets.
Disposable Lancets:
Disposable lancets are used for drawing blood from patients. They are thin, hollow needles made of plastic or metal and contain a sharp point at one end which is inserted into the patient's skin to allow blood withdrawal. The other end is attached to a device that extracts the blood sample and allows it to flow into an collection container.
Application Insights:
The hospital application segment led the global market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. The growth can be attributed to increasing prevalence of diabetes and rising number of hospitals across various regions. For instance, as per WHO, around 599 million people were diagnosed with diabetes worldwide in 2018; out of which 397 million were males and 152 million were females, respectively. Thus, increasing number of patients suffering from diabetes is expected to contribute towards segment growth during the forecast period.
Clinic application accounted for a significant share in 2017 owing to high availability of healthcare services at an affordable cost coupled with advanced equipment required for accurate testing procedures for blood glucose level measurement than that available at hospitals or clinics would lead toward higher shareholding by this segment over the next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, high awareness levels about lancing devices, and availability of advanced treatment options for diabetes management. The region is expected to maintain its dominance throughout the forecast period owing to increasing prevalence rates of diabetes and other associated disorders coupled with rising healthcare expenditure in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure & affordability resulting in increased adoption by patients & physicians for self-testing purposes. Moreover, growing medical tourism industry will also contribute towards regional growth over the coming years. Increasing incidence rate of type 1 diabetes has also been observed among children and adolescents which may further boost demand for these devices during future years (from 2018 - 2030).
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for diabetic lancets, which are used for blood glucose monitoring.
- Technological advancements: Diabetic lancets are witnessing rapid technological advancements, with newer and more innovative products being launched in the market on a regular basis. This has helped to boost their popularity among consumers and has led to an increase in their demand.
- Rising awareness about diabetes: There is a growing awareness about diabetes among people all over the world due to increasing incidences of this disease globally. This has led to an increase in the demand for diabetic lancets as they are essential for blood glucose monitoring purposes .
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetic Lancets Market Research Report
By Type
Reusable Lancets, Disposable Lancets
By Application
Hospital, Clinic, Other
By Companies
Accu Chek, Natus Medical, Ascensia Diabetes Care, Becton Dickinson, Cardinal Health, LifeScan, Owen Mumford, Medisana, Simple Diagnostics, Intrinsyk Medical Devices, Arden Medikal, Arkray, Bauerfeind, BioCare Corporation, Biotest Medical, CML Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Diabetic Lancets Market Report Segments:
The global Diabetic Lancets market is segmented on the basis of:
Types
Reusable Lancets, Disposable Lancets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Accu Chek
- Natus Medical
- Ascensia Diabetes Care
- Becton Dickinson
- Cardinal Health
- LifeScan
- Owen Mumford
- Medisana
- Simple Diagnostics
- Intrinsyk Medical Devices
- Arden Medikal
- Arkray
- Bauerfeind
- BioCare Corporation
- Biotest Medical
- CML Biotech
Highlights of The Diabetic Lancets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Lancets
- Disposable Lancets
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetic Lancets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diabetic lancet is a medical device that is used to measure blood sugar levels.
Some of the key players operating in the diabetic lancets market are Accu Chek, Natus Medical, Ascensia Diabetes Care, Becton Dickinson, Cardinal Health, LifeScan, Owen Mumford, Medisana, Simple Diagnostics, Intrinsyk Medical Devices, Arden Medikal, Arkray, Bauerfeind, BioCare Corporation, Biotest Medical, CML Biotech.
The diabetic lancets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetic Lancets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetic Lancets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetic Lancets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetic Lancets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetic Lancets Market Size & Forecast, 2020-2028
4.5.1 Diabetic Lancets Market Size and Y-o-Y Growth
4.5.2 Diabetic Lancets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Reusable Lancets
5.2.2 Disposable Lancets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetic Lancets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetic Lancets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Reusable Lancets
9.6.2 Disposable Lancets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Reusable Lancets
10.6.2 Disposable Lancets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Reusable Lancets
11.6.2 Disposable Lancets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Reusable Lancets
12.6.2 Disposable Lancets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Reusable Lancets
13.6.2 Disposable Lancets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetic Lancets Market: Competitive Dashboard
14.2 Global Diabetic Lancets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Accu Chek
14.3.2 Natus Medical
14.3.3 Ascensia Diabetes Care
14.3.4 Becton Dickinson
14.3.5 Cardinal Health
14.3.6 LifeScan
14.3.7 Owen Mumford
14.3.8 Medisana
14.3.9 Simple Diagnostics
14.3.10 Intrinsyk Medical Devices
14.3.11 Arden Medikal
14.3.12 Arkray
14.3.13 Bauerfeind
14.3.14 BioCare Corporation
14.3.15 Biotest Medical
14.3.16 CML Biotech
